In response to my last post, I found sponsor responsibilities after the significant risk (SR) versus non-significant risk (NSR) determination. If the IRB decides a study is SR, the sponsor must: S...

I think to add to the discussion of significant risk (SR) versus non-significant risk (NSR) it is useful to read about the considerations that the FDA suggests to the IRB for SR and NSR determination....